Maureen Banach1, Jacques Robert1. 1. Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, USA.
Abstract
A PURPOSE OF REVIEW: Nonmammalian comparative animal models are important not only to gain fundamental evolutionary understanding of the complex interactions of tumors with the immune system, but also to better predict the applicability of novel immunotherapeutic approaches to humans. After reviewing recent advances in developing alternative models, we focus on the amphibian Xenopus laevis and its usefulness in deciphering the perplexing roles of MHC class I-like molecules and innate (i)T cells in tumor immunity. B RECENT FINDINGS: Experiments using MHC-defined inbred and cloned animals, tumor cell lines, effective reagents, sequenced genomes, and adapted gene editing techniques in Xenopus, have revealed that the critical involvement of class I-like molecules and iT cells in tumor immunity has been conserved during evolution. C SUMMARY: Comparative studies with the X. laevis tumor immunity model can contribute to the development of better and more efficient cancer immunotherapies.
A PURPOSE OF REVIEW: Nonmammalian comparative animal models are important not only to gain fundamental evolutionary understanding of the complex interactions of tumors with the immune system, but also to better predict the applicability of novel immunotherapeutic approaches to humans. After reviewing recent advances in developing alternative models, we focus on the amphibian Xenopus laevis and its usefulness in deciphering the perplexing roles of MHC class I-like molecules and innate (i)T cells in tumor immunity. B RECENT FINDINGS: Experiments using MHC-defined inbred and cloned animals, tumor cell lines, effective reagents, sequenced genomes, and adapted gene editing techniques in Xenopus, have revealed that the critical involvement of class I-like molecules and iT cells in tumor immunity has been conserved during evolution. C SUMMARY: Comparative studies with the X. laevis tumor immunity model can contribute to the development of better and more efficient cancer immunotherapies.
Entities:
Keywords:
MHC class I-like; amphibians; innate T cells; tumor immunity; vertebrates
Authors: Jian Wang; Ziquan Cao; Xing-Mei Zhang; Masaki Nakamura; Meili Sun; Johan Hartman; Robert A Harris; Yuping Sun; Yihai Cao Journal: Cancer Res Date: 2014-12-09 Impact factor: 12.701
Authors: Lars Kjer-Nielsen; Onisha Patel; Alexandra J Corbett; Jérôme Le Nours; Bronwyn Meehan; Ligong Liu; Mugdha Bhati; Zhenjun Chen; Lyudmila Kostenko; Rangsima Reantragoon; Nicholas A Williamson; Anthony W Purcell; Nadine L Dudek; Malcolm J McConville; Richard A J O'Hair; George N Khairallah; Dale I Godfrey; David P Fairlie; Jamie Rossjohn; James McCluskey Journal: Nature Date: 2012-10-10 Impact factor: 49.962
Authors: Eva-Stina Edholm; Liz-Marie Albertorio Saez; Ann L Gill; Steven R Gill; Leon Grayfer; Nikesha Haynes; Jason R Myers; Jacques Robert Journal: Proc Natl Acad Sci U S A Date: 2013-08-12 Impact factor: 11.205
Authors: C Athena Aktipis; Amy M Boddy; Gunther Jansen; Urszula Hibner; Michael E Hochberg; Carlo C Maley; Gerald S Wilkinson Journal: Philos Trans R Soc Lond B Biol Sci Date: 2015-07-19 Impact factor: 6.237
Authors: Celia Herrera-Rincon; Jean-Francois Paré; Christopher J Martyniuk; Sophia K Jannetty; Christina Harrison; Alina Fischer; Alexandre Dinis; Vishal Keshari; Richard Novak; Michael Levin Journal: NPJ Regen Med Date: 2020-02-04
Authors: Celia Herrera-Rincon; Jean-Francois Paré; Christopher J Martyniuk; Sophia K Jannetty; Christina Harrison; Alina Fischer; Alexandre Dinis; Vishal Keshari; Richard Novak; Michael Levin Journal: NPJ Regen Med Date: 2020-02-04